Vascular occlusion device
A gold-platinum alloy vascular occlusive device with a braided mesh structure addresses the balance of flexibility, radiopacity, and strength issues, enabling efficient aneurysm occlusion with reduced procedural complexity and tissue trauma.
Patent Information
- Application Number
- CN202411461987.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2018-12-04
- Filing Date
- 2019-11-22
- Publication Date
- 2024-12-06
AI Technical Summary
Existing vascular occlusive devices face challenges in achieving the right balance of flexibility, radiopacity, MRI compatibility, and columnar strength, particularly for wide-necked aneurysms, while also being deliverable through small diameter catheters, leading to complex procedures and potential tissue trauma.
A vascular occlusive device composed of a gold-platinum alloy with a braided mesh portion and optionally spirally wound coils, designed to be at least 5 cm long, with a bending stiffness of less than 150 mN/mm, allowing deployment through small catheters and maintaining shape within aneurysms.
The device provides effective occlusion with reduced procedural complexity, enhanced radiopacity, and MRI compatibility, minimizing tissue trauma and retaining shape within aneurysms without the need for additional stents or balloons.
Smart Images

Figure CN119074115A_ABST
Abstract
Description
[0001] This application is a divisional application of Chinese patent application No. 201980091335.X, entitled “Vascular Occlusion Device”, filed on November 22, 2019. Technical Field
[0002] The present disclosure relates generally to medical devices and endovascular medical procedures, and more particularly, to devices and methods for occluding vascular defects such as aneurysms. Background Art
[0003] Vascular occlusive devices or implants are used for a variety of reasons, including the treatment of intravascular aneurysms. An aneurysm is a dilation of a blood vessel, such as a blood vessel, that may pose a threat to a patient's health due to rupture, clotting, or dissection. For example, a rupture of an aneurysm in a patient's brain may cause a stroke and result in brain damage and death. Cerebral aneurysms may be detected in a patient, for example, after a seizure or hemorrhage, and may be treated by the application of a vascular occlusive device.
[0004] Commonly used vascular occlusive devices include a soft, spirally wound coil formed by winding a platinum (or platinum alloy) wire strand around a "primary" mandrel. The coil is then wrapped around a larger "secondary" mandrel and heat treated to impart a secondary shape. For example, U.S. Pat. No. 4,994,069 to Ritchart et al. (incorporated herein by reference as if fully set forth) describes a vascular occlusive device that exhibits a linear, spiral primary shape when stretched for placement through the lumen of a delivery catheter, and a folded, convoluted secondary shape when released from the delivery catheter and deposited in a blood vessel. In order to better frame and fill aneurysms, complex three-dimensional secondary shapes can be imparted to the vascular occlusive device, and the stiffness / flexibility of the vascular occlusive device can be varied.
[0005] In order to deliver a vascular occlusive device to a desired location in a vessel, such as within an aneurysm sac, it is well known that a small profile delivery catheter or "microcatheter" is first placed at the site using a guidewire. Typically, the distal end of the microcatheter is provided with a selected pre-formed bend, such as a 45°, 26°, "J", "S", or other bend shape, depending on the patient's specific anatomy, by the attending physician or the manufacturer so that once the guidewire is withdrawn, it will remain in the desired position to release one or more vascular occlusive devices into the aneurysm sac. A delivery or "push rod" assembly or "wire" is then passed through the microcatheter until the vascular occlusive device connected to the distal end of the delivery assembly is
[0006] The device is extended from the distal opening of the microcatheter and into the aneurysm sac. Once in the aneurysm sac, portions of the vaso-occlusive device may deform or bend to allow for more effective and complete filling. The vaso-occlusive device is then released or "detached" from the distal end of the delivery assembly, and the delivery assembly is withdrawn through the microcatheter. Depending on the patient's specific needs, one or more additional vaso-occlusive devices may be advanced into the microcatheter and released into the same aneurysm sac.
[0007] Importantly, fluoroscopy is often used to visualize the vascular occlusive device during delivery to the aneurysm, while magnetic resonance imaging (MRI) is often used to visualize the treatment site post-operatively (e.g., a few weeks after the initial treatment of the aneurysm) to ensure proper occlusion of the aneurysm sac. Therefore, it is important that the vascular occlusive device be constructed in a manner that enables it to achieve its radiopacity during the treatment of the aneurysm while minimizing any visualization blurring artifacts produced during post-operative MRI (i.e., MRI compatible). It is also important that such a vascular occlusive device be "soft" (i.e., laterally flexible or compliant) and therefore atraumatic to prevent rupture of the delicate tissue of the aneurysm.
[0008] It is also important to retain such vascular occlusive devices within the aneurysm for a long period of time. However, large-mouthed aneurysms, commonly referred to as "wide-necked aneurysms," present difficulties in placing and retaining vascular occlusive devices within the aneurysm sac, particularly for smaller and relatively thin vascular occlusive coils, which, no matter how expertly they are placed, lack substantial secondary shape strength to remain in place within these aneurysm sacs. For this reason, a stent or balloon must be deployed in a vessel near the neck region of the aneurysm to ensure that the vascular occlusive coil is retained within the aneurysm sac, complicating the procedure. To address this particular problem, vascular occlusive devices have been developed that are at least partially composed of a braided (or woven) structure. Such braided vascular occlusive devices provide greater coverage and a more effective skeleton across the neck of the aneurysm, and can therefore be effectively retained within a wide-necked aneurysm without the need to deploy a supplemental aneurysm retention device, such as a balloon or stent.
[0009] However, regardless of whether a coiled or braided vascular occlusive device is used, conventional vascular occlusive device delivery systems require that such vascular occlusive devices be relatively short and have limited expandability, otherwise they are difficult (if not impossible) to push into and / or retrieve from a microcatheter. Unfortunately, smaller (shorter) vascular occlusive devices are less desirable because delivering such smaller vascular occlusive devices into an aneurysm sac may require a longer and more complicated procedure. For example, a 7 mm diameter neurovascular aneurysm sac may typically be filled with 5 to 7 individual spring-shaped coils, resulting in a longer and more complicated procedure than reducing the number of devices.
[0010] In theory, the length of the vascular occlusive device can be increased to reduce the number of such vascular occlusive devices required to treat an aneurysm. However, increasing the length of the vascular occlusive device will inevitably increase the friction of the vascular occlusive device with the lumen of the delivery catheter. Thus, the columnar strength of the vascular occlusive device must be increased (e.g., by selecting a material with a high Young's modulus or increasing the diameter of the wire forming the vascular occlusive device) and / or the diameter of the delivery catheter must be increased to ensure that the vascular occlusive device can be delivered into the aneurysm. However, as described above, it is important that the diameter of the delivery catheter be as small as possible to allow access to the aneurysm through very small blood vessels, and that the vascular occlusive device be sufficiently flexible to prevent trauma to the delicate tissue of the aneurysm.
[0011] Materials that achieve relatively long vascular occlusions with the necessary columnar strength for delivery through relatively small diameter delivery catheters while meeting other countervailing requirements, including flexibility, radiopacity, and MRI compatibility requirements, are very limited.
[0012] For example, known materials having relatively high Young's modulus and relatively high radiopacity, such as platinum tungsten (PtW) alloys from which vaso-occlusive coils are typically made, may be used in an attempt to provide the necessary columnar strength for relatively long vaso-occlusive devices; however, the diameter of the wire from which such vaso-occlusive devices are made must be reduced to meet flexibility requirements while allowing the vaso-occlusive devices to fit within a small diameter delivery catheter. As a result, the vaso-occlusive device will have reduced radiopacity and reduced columnar strength, which will require a shortened vaso-occlusive device and / or a larger diameter delivery catheter.
[0013] As another example, known materials having relatively low Young's modulus and low radiopacity, such as Nitinol, may be used in an attempt to provide the necessary softness to a vaso-occlusive device; however, such a vaso-occlusive device would not have the desired radiopacity and columnar strength necessary to increase the length of the vaso-occlusive device. Furthermore, the heating process used to set the Nitinol into a predetermined shape can cause surface oxides to crack and release toxic nickel. Therefore, such oxides must be removed from the vaso-occlusive device using an expensive and time-consuming process.
[0014] As yet another example, if selecting an optimal diameter for a guidewire for manufacturing such a vaso-occlusive device, one might attempt to use a known material having a relatively intermediate Young's modulus and low radiopacity, such as titanium, to provide the necessary columnar strength for a relatively long and flexible vaso-occlusive device; however, such a vaso-occlusive device would not exhibit the necessary radiopacity.
[0015] Therefore, there continues to be a need to provide a vascular occlusive device that meets the above requirements. Summary of the invention
[0016] According to one aspect of the invention, a vascular occlusive device includes an elongated vascular occlusive structure (e.g., at least 5 cm in length) configured for implantation in an aneurysm sac. The vascular occlusive structure has a delivery configuration when restrained within a delivery catheter, and has a deployed configuration when released from the delivery catheter into the aneurysm sac. At least a portion of the vascular occlusive structure is composed of a gold-platinum (AuPt) alloy, e.g., containing platinum in the range of 25%-40% by weight and having a thickness of less than 25×10 6 Young's modulus in pounds per square inch (psi). The vascular occlusive structure may further be composed of one or both of iridium and tungsten.
[0017] In one embodiment, the vascular occlusive structure includes a mesh portion (e.g., a braided portion) composed of an AuPt alloy. The mesh portion may have a bending stiffness of less than 150 mN / mm. The entire vascular occlusive structure includes a mesh portion, or alternatively, the vascular occlusive structure may also include two spirally wound coil portions disposed at opposite ends of the mesh portion. The coil portion may be composed of an AuPt alloy. The mesh portion may include at least one wire (e.g., 8-96 wires), each wire having a minimum cross-sectional dimension, for example, in the range of 0.0008"-0.004". Each wire (multiple) may, for example, have a circular cross-section or a rectangular cross-section. Each wire may have, for example, a single strand or a twisted strand. If the mesh is a braided portion, the unconstrained braiding angle of the braided portion is in the range of 20°-130°, preferably in the range of 20°-60°. The mesh portion may have an extended geometry, for example, with a circular cross section or a flat cross section (eg, with a width in the range of 0.5 mm - 5.0 mm, preferably in the range of 1.0 mm - 2.0 mm).
[0018] The vaso-occlusive device can be incorporated into a vaso-occlusive assembly that also includes a pusher member to which the vaso-occlusive device is removably (eg, electrolytically) connected. The vaso-occlusive assembly can be incorporated into a vaso-occlusive treatment system that includes a delivery catheter in which the vaso-occlusive assembly is disposed.
[0019] Other and further aspects and features of embodiments of the disclosed invention will become apparent from the following detailed description taken in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] The drawings illustrate the design and utility of the preferred embodiments of the present invention, wherein similar elements are referred to by common reference numerals. It should be noted that the drawings are not drawn to scale, and throughout the drawings, elements of similar structure or function are represented by similar reference numerals. It should also be noted that the drawings are intended only to facilitate the description of the embodiments. They are not intended to be an exhaustive description of the invention or a limitation on the scope of the invention, which is limited only by the appended claims and their equivalents. In addition, the illustrated embodiments of the disclosed invention do not necessarily have all the aspects or advantages shown. The aspects or advantages described in conjunction with the specific embodiments of the disclosed invention are not necessarily limited to that embodiment, and may be practiced in any other embodiments even if not illustrated. In order to better understand how to obtain the above and other advantages and purposes of the present invention, the invention briefly described above will be described in more detail by reference to its specific embodiments, which are shown in the drawings. It is understood that these drawings depict only typical embodiments of the present invention and should not be considered as limitations on the scope of the invention, and the present invention will be described and explained with additional features and details by using the drawings, wherein:
[0021] Figure 1 is a side view of a vascular occlusion treatment system constructed in accordance with one embodiment of the present invention, particularly illustrating a vascular occlusion within a delivery catheter in a delivery configuration;
[0022] Figure 2 yes Figure 1 A side view of a vascular occlusive treatment system of FIG. 1 , particularly showing a vascular occlusive device deployed from a delivery catheter in an expanded configuration;
[0023] Figure 3 It is expanded within the aneurysm sac Figure 1 A plan view of a vascular occlusion structure of a vascular occlusion treatment system;
[0024] Figure 4 yes Figure 1 A plan view of a mesh portion of a vascular occlusive structure of a vascular occlusive treatment system;
[0025] Figure 5A is Figure 4 A cross-sectional view of one embodiment of a wire used in a mesh portion of;
[0026] Figure 5B is Figure 4 A cross-sectional view of another embodiment of a wire used in a mesh portion of;
[0027] Figure 5C is Figure 4 A cross-sectional view of yet another embodiment of a wire used in a mesh portion of;
[0028] Fig. 6Ayes Figure 1 A cross-sectional view of one embodiment of a mesh portion of a vascular occlusion treatment system;
[0029] Figure 6B yes Figure 1 A cross-sectional view of another embodiment of a mesh portion of a vascular occlusion treatment system;
[0030] Fig. 7A is a fluoroscopic image of a prototype of a vascular occlusive structure constructed according to the present invention;
[0031] Figure 7B is a perspective image of a prototype of another vascular occlusive structure constructed according to the present invention;
[0032] Fig. 8A is an MRI image of a prototype of an aneurysm filled with a conventional Pt / 8W vascular occlusive coil;
[0033] Figure 8B is an MRI image of a prototype of an aneurysm filled with Au / Pt vascular occlusive coil constructed according to one embodiment of the present invention;
[0034] Fig. 9 is a side view of a vascular occlusion treatment system constructed in accordance with another embodiment of the present invention, particularly illustrating a vascular occlusion within a delivery catheter in a delivery configuration; and
[0035] Fig.10 yes Fig. 9 Side view of a vascular occlusive treatment system, particularly showing a vascular occlusive device in an expanded configuration deployed from a delivery catheter. DETAILED DESCRIPTION
[0036] Reference Figure 1 and Figure 2 One embodiment of a vascular occlusion treatment system 10 constructed in accordance with the present invention will now be described. The vascular occlusion treatment system 10 includes a delivery catheter 12 and a vascular occlusion assembly 14 slidably disposed within the delivery catheter 12. The vascular occlusion assembly 14 includes a vascular occlusion structure 16 and a push rod member 18 to which the vascular occlusion structure 16 is detachably connected at a joint 20.
[0037] The delivery catheter 12 has a tubular configuration and may, for example, take the form of a microcatheter or the like. The delivery catheter 12 includes an elongated sheath body 22 having a proximal portion 24 and a distal portion 26, and a lumen 28 (shown in phantom) extending through the sheath body 22 between the proximal portion 24 and the distal portion 26. When the vascular occlusion treatment system 10 is in use, the proximal portion 24 of the sheath body 22 remains external to the patient and accessible to an operator, while the distal portion 26 of the sheath body 22 is sized and dimensioned to reach a distal location in a blood vessel and is configured to deliver the vascular occlusive structure 16 to the aneurysm. The delivery catheter 12 may have at least one port 30 in fluid communication with the lumen 28 of the delivery catheter 12 for introducing a fluid into the sheath body 22. The vascular occlusive assembly 14 is disposed in the lumen 28 of the delivery catheter 12, such as Figure 1 Best shown.
[0038] Delivery catheter 12 may include one or more, or multiple, regions with different configurations and / or characteristics along its length. For example, the outer diameter of the distal portion 26 of sheath body 22 may be less than the outer diameter of the proximal portion 24 of sheath body 22 to reduce the profile of the distal portion 26 and help navigate in tortuous blood vessels. In addition, the distal portion 26 may be more flexible than the proximal portion 24. Typically, the proximal portion 24 may be formed of a harder material than the distal portion 26 of the sheath body 22 so that the proximal portion 24 has enough pushing power to advance through the patient's vascular system, while the distal portion 26 may be formed of a softer material so that the distal portion 26 can remain soft and more easily tracked on a guidewire to enter a distal position in a curved region of a blood vessel. The sheath body 22 may be made of a suitable polymer material, metal and / or alloy, such as polyethylene, stainless steel or other suitable biocompatible materials or a combination thereof. In some cases, the proximal portion 24 may include a reinforcing layer, such as a braided layer or a coiled layer, to enhance the pushability of the sheath body 22. The sheath body 22 may include a transition region between the proximal portion 24 and the distal portion 26 .
[0039] Typically, the vascular occlusive structure 16 can be inserted into the patient's body by inserting (e.g., minimally invasively) the vascular occlusive treatment system 10 into the patient's blood vessel to reach the aneurysm site. Therefore, the delivery catheter 12 is made as small as possible and has a very narrow inner diameter (i.e., lumen 28) (e.g., between 0.015" and 0.025", and preferably 0.015" and 0.018"). The vascular occlusive treatment system 10 can be used in an "on-the-line" configuration, in which the delivery catheter 12 is introduced into the patient's body over a guidewire that has been previously introduced, and the delivery catheter 12 extends over the entire length of the guidewire (not shown). Alternatively, the vascular occlusive treatment system 10 can be used in a "quick exchange" configuration, in which the guidewire extends only from a guidewire port (not shown) through the distal portion of the vascular occlusive treatment system 10. In other alternative embodiments, the VOT system 10 may be introduced into the patient after the guidewire is withdrawn, thereby leaving a sheath or access catheter distal portion at the target site for the VOT system 10 to navigate within the sheath or access catheter through the patient's vessel.
[0040] At the aneurysm site, the vascular occlusive structure 16 can be pushed out from the distal end of the delivery catheter 12 in the parent vessel V through the aneurysm neck N and into the aneurysm sac A by the push rod member 18. Figure 3 As shown. After being extruded from the delivery catheter 12, the vascular occlusive structure 16 can self-expand into a preset configuration as described below. Once the vascular occlusive structure 16 is inserted into the aneurysm sac A, the vascular occlusive structure 16 can be decoupled from the push rod member 18. A sufficient number of vascular occlusive devices 16 can be delivered to fill and occlude the aneurysm sac A. The vascular occlusive structure 16 can also be removed or withdrawn and folded back into the delivery catheter 12 by withdrawing the vascular occlusive structure 16 proximally via the push rod member 18.
[0041] The push rod member 18 may be a coil, wire, tendon, etc., having sufficient columnar strength to allow the vaso-occlusive structure 16 to be pushed into the aneurysm sac. The junction 20 where the push rod member 18 connects to the vaso-occlusive structure 16 may, for example, take the form of an electrolytically degradable segment for electrolytically decoupling the vaso-occlusive structure 16 from the push rod member 18, although other alternative separation mechanisms for decoupling the vaso-occlusive structure 16 from the push rod member 18 may include mechanical, thermal, and hydraulic mechanisms.
[0042] The push rod member 18 has a proximal portion 32, which extends proximally from the proximal portion 24 of the delivery catheter 12 and the distal portion 34 to which the vascular occlusion device 14 is attached. The push rod member 18 can be made of a conventional guide wire, a twistable cable tube or a hypotube. In either case, the push rod member 18 can use many materials to achieve the desired performance usually associated with the medical device. Some examples may include metals, metal alloys, polymers, metal-polymer composites, etc., or any other suitable material. For example, the push rod member 18 may include a composite material of nickel-titanium alloy, stainless steel, nickel-titanium alloy and stainless steel. In some cases, the push rod member 18 may be made of the same material along its length, or in some embodiments, may include parts or segments made of different materials. In some embodiments, the material used to construct the push rod member 18 is selected to impart different flexibility and stiffness properties to different parts of the push rod member 18. For example, the proximal region and the distal portion 34 of the push rod member 18 may be formed of different materials, such as materials with different elastic moduli, resulting in differences in flexibility. For example, the proximal portion 32 may be formed of stainless steel, and the distal portion 34 may be formed of a nickel titanium alloy. However, any suitable material or combination of materials may be used for the pusher member 18, as desired.
[0043] The vascular occlusive structure 16 is sized for implantation in an aneurysm sac A, which may have any geometric structure or shape in cross-section. For example, in the illustrated embodiment, the vascular occlusive structure 16 takes the form of an elastic tubular member having a proximal end 36 and a distal end 38. In this case, the distal end 38 of the vascular occlusive structure 16 is typically free or loose (allowing maximum expansion), while the proximal end 36 of the vascular occlusive structure 16 is connected / attached to the push rod member 18. Therefore, the distal end 38 of the vascular occlusive structure 16 is free-floating. For another example, the vascular occlusive structure 16 may take the form of a flat member in which both the proximal and distal ends may be fixed (allowing minimum expansion). The vascular occlusive structure 16 has a compact delivery configuration when it is radially constrained within the delivery catheter 12, and is biased to expand radially outward into an expanded configuration when released from the delivery catheter 12 into the aneurysm sac. The cross-sectional dimension of the vaso-occlusive structure 16 in the expanded deployed configuration may be, for example, greater than 1.5 times, and preferably greater than 2 times, and most preferably greater than 3 times, the cross-sectional dimension of the vaso-occlusive structure 16 in its compact delivery configuration. The expanded deployed configuration of the vaso-occlusive structure 16 may be preset and may be curved, bent, or three-dimensional (e.g., spherical, toroidal, etc.), and may include secondary or tertiary structures.
[0044] It is noteworthy that the inventors have found that platinum (AuPt) alloys (preferably containing 25%-40% by weight of platinum and less than 25×10 6A Young's modulus of 1000 psi enables a vascular occlusive structure 16 to be realized, given a suitable structure, to exhibit the necessary softness (e.g., bending stiffness less than 150 mN / mm), a desired length (e.g., greater than 5 cm), compatibility with small diameter delivery catheters (e.g., 0.017" inner diameter), sufficient radiopacity, sufficient MRI compatibility, and ease of manufacturing (e.g., no surface oxide removal required). Therefore, at least a portion of the vascular occlusive structure 16 is composed of an AuPt alloy. In addition to the AuPt alloy, the vascular occlusive structure 16 may also be composed of iridium and / or tungsten to improve its mechanical properties.
[0045] exist Figure 1 and Figure 2 In the illustrated embodiment, the entire vaso-occlusive structure 14 includes a porous mesh portion 40 comprised of an AuPt alloy, although, as will be discussed in further detail below, only a portion of the vaso-occlusive structure 16 may include the mesh portion 40. In the illustrated embodiment, the mesh portion 40 is formed by braiding or interweaving together wires 42 (e.g., the number of wires being in the range of 8-96 wires, typically in the range of 16-32 wires), although in alternative embodiments, the mesh portion 40 may be formed as a unitary structure, for example, by etching or cutting a pattern from a tube or sheet of stent material, or by cutting or etching a sheet of material in a desired pattern so that the sheet can be rolled or otherwise formed into a desired substantially tubular, bifurcated, or other shape.
[0046] The mesh portion 40 can have a desired length (e.g., greater than 5 cm, 5 cm to 45 cm, 5 cm to 30 cm, etc.). The braid can be formed using a braiding machine and can be woven around a mandrel (e.g., the mandrel has a circular, oval, flat, or other shape depending on the desired final cross-sectional shape of the vascular occlusive structure 16). Alternatively, the wire 42 can be woven into a flat braid and then formed and heat-set around the mandrel into a flat braid having a predetermined shape. After braiding, the mesh portion 40 can be heat-set (e.g., at 450° C. to 650° C. for 1 minute to 60 minutes). The heat-set braid forms a linear "primary shape" of the mesh portion 40. The heat-set braid can then be wrapped around a second mandrel (e.g., a three-dimensional mandrel) and heat-set a second time to impart a three-dimensional "second shape" or "third shape."
[0047] Each line 42 may be a monofilament strand, such as Figure 5A and Figure 5B As shown, although in alternative embodiments, each wire 42 may be a multifilament strand, such as Figure 5C Each wire 42 may have any suitable cross-section and any suitable size. For example, if the cross-section of each wire 42 is circular (e.g. Figure 5A As shown), the diameter can be in the range of 0.0008"-0.0040", and if the cross section of each wire 42 is rectangular (as shown in FIG. Figure 5B ), the thickness may be greater than 0.0008", and the width may be less than 0.005". In another embodiment, each wire 42 may be in the form of a stranded wire (eg Figure 5C ), to enhance the flexibility of the resulting vascular occlusive structure 16.
[0048] Although all of the wires 42 that make up the mesh portion 40 may have the same size and composition, it should be understood that the wires 42 may have different sizes and compositions, as long as at least some of the wires 42 that make up the structure of the vascular occlusive structure 16 are composed of an AuPt alloy. Preferably, the mesh portion 40 has an unconstrained braid angle 44 (i.e., the angle between two intersecting wires 42) in the range of 20°-130°, more preferably in the range of 20°-60°. Typically, the braid angle 44 may be the angle between two intersecting wires 42 observed in the longitudinal direction. Selecting the braid angle 44 may enhance the pushability of the vascular occlusive structure 16 within the delivery catheter 12 by preventing the collapse of the mesh portion 40, which may otherwise cause the mesh portion 40 to bunch in the delivery catheter 12 when pushed and cause occlusion of the vascular occlusive structure 16 within the delivery catheter 12. Ultimately, the number of wires 42 in the mesh portion 40, the braid angle 44, and / or the expanded configuration relative to the collapsed configuration of the mesh portion 40 may be selected to best fit the inner diameter of the delivery catheter 12 used.
[0049] exist Fig. 6A In one embodiment shown, the mesh portion 40 has an extended geometry that is flat (e.g., ribbon-like) and may have a width in the range of, for example, 0.5 mm to 5.0 mm, although in Figure 6B In the alternative embodiment shown, the mesh portion 40 can have a cylindrical expanded geometry (i.e., having a circular cross-section) and can, for example, have a diameter in the range of 0.5 mm to 5.0 mm. Thus, the mesh portion 40 can be a flat braid or a circular braid. Through prototyping and testing, the exact composition of the AuPt alloy, the size and number of wires 42 and braid angles used to construct the mesh portion 40 of the vascular occlusive structure 16, and the shape and size of the expanded vascular occlusive structure 16 can be optimized for superior performance as required by the target application.
[0050] For example, a relatively soft and long but radiopaque vascular occlusion device prototype was constructed by braiding twenty-four wires at a braid angle of 32° into a flat braid with a width of 1.25 mm and a length of 25 cm. Each wire was composed of AuPt34 with a Young's modulus of 19 Msi and a wire diameter of 0.001". Vascular occlusion can be achieved by The microcatheter (0.026" OD, 0.0165" ID) was delivered with a friction of less than 0.06 lbs and was shown to have adequate shape retention, good bending stiffness (44.45 mN / mm) and good radiopacity at x-ray energies of 82 kVp, as Fig. 7A shown.
[0051] As another example, another relatively soft and long but radiopaque vascular occlusion device prototype was constructed by braiding twenty-four wires at a braid angle of 32° into a flat braid with a width of 1.25 mm and a length of 25 cm. Each wire was composed of AuPt29 with a Young's modulus of 17 Msi and a wire diameter of 0.001 15". The vascular occlusion can be achieved by The device was delivered via a microcatheter (0.026" OD, 0.0165" ID) with a friction of less than 0.06 lbs and was demonstrated to have adequate shape retention, good bending stiffness (67.33 mN / mm) and good radiopacity at 82 KVp x-ray energy. It should be noted that although this vaso-occlusive device is not as flexible as the vaso-occlusive device discussed immediately above (67.33 mN / mm vs. 44.45 mN / mm), this vaso-occlusive device has better radiopacity, as Figure 7B shown.
[0052] As yet another example, the MR compatibility properties of a prototype vascular occlusive device in the form of a helically wound coil composed of AuPt29 were compared to a helically wound coil composed of conventional Pt / 8W. A 6 mm aneurysm was filled with a vascular occlusive coil composed of AuPt29 at a packing density of 35%, and the site was imaged by MRI at 3 T (see Figure 8B ), while the same 6 mm aneurysm was filled with a vascular occlusive coil composed of conventional Pt / 8W at a packing density of 35% and the site was imaged by MRI at 3 T (see Fig. 8A ). It can be appreciated that the MRI images of the conventional Pt / 8W vascular occlusive coil have artifacts, such as interface artifacts, while the MRI images of the novel AuPt29 vascular occlusive coil advantageously lack such interface artifacts.
[0053] As briefly discussed above, only a portion of the vaso-occlusive structure 16 may include the mesh portion 40. For example, Fig. 9 and Fig.10As shown, another embodiment of a vascular occlusion treatment system 10' constructed in accordance with the present invention will now be described. The vascular occlusion treatment system 10' is similar to the vascular occlusion treatment system 10, except that the vascular occlusive structure 16' includes a central mesh portion 40' and two helically wound coil portions 39a, 39b disposed at opposite ends of the central mesh portion 40'. The central mesh portion 40' may be connected to a vascular occlusion treatment system 10'. Figure 1 and Figure 2 The mesh portion 40 is constructed in the same manner as described above. Preferably, the coil portions 39a, 39b are composed of an AuPt alloy. Notably, the coil portions 39a, 39b provide an additional non-invasive feature to the vascular occlusive structure 16'.
[0054] Although respectively Figure 1-Figure 2 and Figure 9-10 The vascular occlusive structure 16, 16' shown in FIG. 1 can be described as having a single braided layer,
[0055] It should be understood that the vaso-occlusive structure may include multiple braid layers (i.e., braid on braid structure), or may even include one braid layer (e.g., outer layer of braid) and coil layers (e.g., inner coil) (i.e., braid on coil structure). In either case, all layers of the vaso-occlusive structure are preferably composed of AuPt alloy.
[0056] Although specific embodiments of the disclosed invention have been shown and described herein, it will be understood by those skilled in the art that they are not intended to limit the invention, and it will be apparent to those skilled in the art that various changes and modifications (e.g., the dimensions of the various parts) may be made without departing from the scope of the disclosed invention, which is limited only by the appended claims and their equivalents. Therefore, the specification and drawings should be considered illustrative rather than restrictive. The various embodiments of the disclosed invention shown and described herein are intended to cover alternatives, modifications, and equivalents of the disclosed invention, which may be included within the scope of the appended claims.
Claims
1. A vascular occlusive device comprising: An elongated vascular occlusive structure comprising a mesh body configured for implantation in an aneurysm sac, the mesh body having a collapsed delivery configuration when constrained within a delivery catheter and biased to self-expand into an expanded deployed configuration when released from the delivery catheter into the aneurysm sac, wherein in the collapsed delivery configuration, the mesh body has a first cross-sectional dimension, and in the expanded deployment configuration, the mesh body has a second cross-sectional dimension, the second cross-sectional dimension being greater than the first cross-sectional dimension, wherein the mesh body comprises braided alloy wires made of a gold-platinum (AuPt) alloy, the AuPt alloy comprising platinum in the range of 25%-40% by weight; and Wherein, when the mesh body is located in the delivery catheter, the friction between the vascular occluding device and the delivery catheter is less than 0.06 lbs.
2. The vascular occlusive device according to claim 1, wherein: The mesh body is sufficiently flexible to limit the normal force applied by the mesh body toward the delivery catheter such that when the mesh body is within the delivery catheter, the friction between the vaso-occlusive device and the delivery catheter is less than 0.06 lbs.
3. The vaso-occlusive device according to claim 1, wherein: When in the collapsed delivery configuration within the delivery catheter, the mesh body has sufficient columnar strength that allows the mesh body to be pushed through the lumen of the delivery catheter.
4. The vaso-occlusive device according to claim 3, wherein: When constrained within the delivery catheter, the first cross-sectional dimension of the mesh body is less than 0.025", and wherein the mesh body having the first cross-sectional dimension less than 0.025" has sufficient columnar strength to allow the mesh body to be pushed through the lumen of the delivery catheter.
5. The vaso-occlusive device according to claim 1, wherein: At least a portion of the mesh body is configured to expand from the first cross-sectional size to a second cross-sectional size that is greater than 2 times the first cross-sectional size when outside the delivery catheter.
6. The vascular occlusive device of claim 1, wherein the AuPt alloy has a 6 Young's modulus in pounds per square inch (psi).
7. The vaso-occlusive device of claim 1, further comprising a first helically wound coil portion and a second helically wound coil portion disposed at respective opposite ends of the mesh body.
8. The vaso-occlusive device of claim 1, wherein each of the alloy wires has a cross-sectional dimension in the range of 0.0008" to 0.004".
9. The vaso-occlusive device of claim 1, wherein the mesh body has a thread count in the range of 8 to 96 threads.
10. The vaso-occlusive device of claim 1, wherein the mesh body has a thread count in the range of 16-32 threads.
11. The vaso-occlusive device of claim 1 , wherein in the expanded deployed configuration, the mesh body has a braid angle in the range of 20°-60°.
12. The vaso-occlusive device of claim 1, wherein in the expanded deployed configuration, the mesh body has a circular cross-section.
13. The vaso-occlusive device of claim 1, wherein in the expanded deployed configuration, the mesh body has a rectangular cross-section.
14. The vaso-occlusive device of claim 13, wherein the width of the rectangular cross-section is in the range of 1.0 mm-2.0 mm.
15. The vaso-occlusive device of claim 1, wherein in the expanded deployed configuration, the mesh body has a bending stiffness of less than 150 mN / mm.
16. A vascular occlusive device delivery system comprising: The vascular occlusive device according to any one of claims 1 to 15; and A push rod member assembly has a distal portion to which the vaso-occlusive device is removably connected.
17. The vaso-occlusive device delivery system of claim 16, further comprising a delivery catheter, the push rod member assembly being disposed in the delivery catheter.
Citation Information
Patent Citations
Vascular stenting for aneurysms
CN102573701A
Embolization coil and method for manufacturing embolization coil
EP3391833A1
Indwelling instrument for forming embolus
US20060173488A1
Embolic medical devices
US20150297240A1
Micrograft for the treatment of intracranial aneurysms and method for use
US20160206419A1
